J
Juva Life Inc
CNSX:JUVA
Juva Life Inc
CNSX:JUVA
Price:
0.02
CAD
Market Cap:
CA$2.5m
Relative Value
There is not enough data to reliably calculate the relative value of JUVA.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
JUVA
Relative Value
Base Case
Not Available
Multiples Across Competitors
JUVA Competitors Multiples
Juva Life Inc Competitors
Juva Life Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
J
|
Juva Life Inc
CNSX:JUVA
|
2.5m CAD | 0.2 | -0.2 | -1.4 | -1.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
993.7B USD | 15 | 47.5 | 32 | 34.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
600.4B USD | 6.4 | 22.4 | 15.5 | 19 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
288.1B CHF | 4.7 | 30.6 | 12.9 | 15.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
249.3B CHF | 5.7 | 23 | 14.2 | 18.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.2B GBP | 5.4 | 31.2 | 17.3 | 24.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
304.1B USD | 4.6 | 16.6 | 10.2 | 12.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.3B USD | 2.5 | 20.1 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.5B USD | 2.6 | 17.9 | 7.5 | 9.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
